Health Care: Drugs

Neostem Inc (NBS: NASDAQ)

$2.79 n/a | n/a%
05/01/15 - 03:59 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 17.94M 14.67M 14.33M 73.72M
Cost of Sales 13.49M 11.34M 8.79M 44.56M
Gross Operating Profit 4.45M 3.33M 5.54M 29.16M
Selling, General, and Administrative Expenses 30.81M 21.61M 22.32M 41.85M
Research & Development 29.19M 16.92M 10.45M 11.00M
Operating Income before D & A (EBITDA) -55.55M -35.20M -27.23M -23.69M
Depreciation & Amortization 2.19M 1.61M 3.16M 11.42M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 2.93M -1.61M -4.31M 2.34M
Special Income / Charges 0.00 0.00 0.00 -19.43M
Total Income Before Interest Expenses (EBIT) -54.81M -38.42M -34.70M -52.20M
Interest Expense 755.70K 281.42K 1.58M 3.99M
Pre-Tax Income -55.57M -38.71M -36.28M -56.19M
Income Taxes -104.20K 780.10K -175.53K 392.77K
Minority Interest -593.31K -504.09K -12.60M -9.45M
Net Income From Continuing Operations -55.47M -39.49M -36.10M -56.58M
Net Income From Discontinued Operations 0.00 0.00 -30.27M 0.00
Net Income From Total Operations -55.47M -39.49M -66.37M -56.58M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -54.87M -38.98M -53.77M -47.13M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-55.47M -39.49M -36.10M -37.15M
Preferred Dividends
Net Income Available To Common -55.47M -39.49M -36.63M -57.22M
Basic EPS from Continuing Ops. -1.68 -1.90 -2.60 -5.39
Basic EPS from Discontinued Ops. 0.00 0.00 -1.30 0.00
Basic EPS from Total Operations -1.68 -1.90 -3.90 -5.39
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 -0.10 -0.01
Basic EPS, Total -1.68 -1.90 -4.00 -5.40
Basic Normalized Net Income/Share -1.68 -1.90 -2.60 -3.54
EPS fr Continuing Ops. -1.68 -1.90 -2.60 -5.39
EPS fr Discontinued Ops 0.00 0.00 -1.30 0.00
EPS fr Total Ops. -1.68 -1.90 -3.90 -5.39
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 -0.10 -0.01
EPS, Total -1.68 -1.90 -4.00 -5.40
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.68 -1.90 -2.60 -3.54
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NBS

Latest NBS Headlines from TheStreet

More Financial News for NBS

Press Releases for NBS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter